{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:02:14Z","timestamp":1783497734120,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.dld.2007.01.012","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T07:02:48Z","timestamp":1173337368000},"page":"329-337","source":"Crossref","is-referenced-by-count":49,"title":["Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study"],"prefix":"10.1016","volume":"39","author":[{"given":"L.","family":"Biancone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gionchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Del Vecchio","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Annese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sostegni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"D\u2019Inc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Petruzziello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Casa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Campieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2007.01.012_bib1","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/bmj.2.5104.1072","article-title":"Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium. A report on a controlled therapeutic trial","volume":"2","author":"Truelove","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2007.01.012_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/bmj.1.5171.464","article-title":"Systemic and local corticosteroids therapy in ulcerative colitis","volume":"1","author":"Truelove","year":"1960","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2007.01.012_bib3","first-page":"1826","article-title":"Treatment of ulcerative colitis with rectal steroids","author":"McDougal","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2007.01.012_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/gut.20.5.349","article-title":"Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema","volume":"20","author":"Lee","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.dld.2007.01.012_bib5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(87)92900-X","article-title":"Systemic absorption from hydrocortisone foam enema in ulcerative colitis","volume":"i","author":"Cann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2007.01.012_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1155\/1990\/708916","article-title":"Overview of newer glucocorticosteroid preparations for inflammatory bowel disease","volume":"4","author":"Brattsand","year":"1990","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.dld.2007.01.012_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0002-9343(92)90051-C","article-title":"New therapeutic agents in the treatment of inflammatory bowel disease","volume":"93","author":"Geier","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2007.01.012_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003495-198428020-00002","article-title":"Beclomethasone dipropionate: a reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis","volume":"28","author":"Brogden","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2007.01.012_bib9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.104.5.1565","article-title":"What role for inhaled steroids in chronic asthma?","volume":"104","author":"Busse","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.dld.2007.01.012_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(82)91747-0","article-title":"Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producting Cushing's sindrome or hypothalamic pituitary adrenal suppression","volume":"1","author":"Kumana","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2007.01.012_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF02556177","article-title":"Treatment of distal ulcerative colitis with beclomethasone enemas: high therapeutic efficacy without endocrine side-effects","volume":"30","author":"Bansky","year":"1987","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.dld.2007.01.012_bib12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0016-5085(87)90980-2","article-title":"Coating of oral beclomethasone dipropionate capsules with cellulose acetate phtalate enhances delivery of topically active antiinflammatory drug to terminal ileum","volume":"92","author":"Levine","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2007.01.012_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00004836-199102000-00009","article-title":"A controlled trial of beclomethasone versus beclomethasone enemas in distal ulcerative colitis","volume":"13","author":"Halpern","year":"1991","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2007.01.012_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2036.1998.00299.x","article-title":"Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis","volume":"12","author":"Campieri","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2007.01.012_bib15","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","article-title":"5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis proctosigmoiditis and proctitis","volume":"92","author":"Sutherland","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2007.01.012_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00042737-199606000-00010","article-title":"Beclomethasone dipropionate (3mg) versus 5-aminosalicylic acid (2g) versus the combination of both (3mg\/2g) as retention enemas in active ulcerative proctitis","volume":"8","author":"Mulder","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2007.01.012_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.mcg.0000155124.74548.61","article-title":"Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalazine: a single-blind randomized controlled trial","volume":"39","author":"Gionchetti","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2007.01.012_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2007.01.012_bib19","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.1.4979.1315","article-title":"Biopsy studies in ulcerative colitis","volume":"1","author":"Truelove","year":"1956","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2007.01.012_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gut.50.suppl_3.iii43","article-title":"New steroids and new salicylates in inflammatory bowel disease: a critical appraisal","volume":"50","author":"Campieri","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.dld.2007.01.012_bib21","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1046\/j.1365-2036.2003.01609.x","article-title":"Oral beclomethasone dipropionate in the treatment of estensive and left-sided active ulcerative colitis: a multicentre randomised study","volume":"17","author":"Campieri","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2007.01.012_bib22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1365-2036.2002.01298.x","article-title":"Oral beclomethasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study","volume":"16","author":"Rizzello","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2007.01.012_bib23","first-page":"415","article-title":"Rectal pharmacokinetics of budesonide","volume":"4","author":"Dahlstrom","year":"1990","journal-title":"Eur J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2007.01.012_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2036.1994.tb00340.x","article-title":"Budesonide versus prednisolone retention enemas in active distal ulcerative colitis","volume":"8","author":"Lofberg","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2007.01.012_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1155\/1990\/583849","article-title":"Budesonide enemas for topical therapy of ulcerative colitis","volume":"4","author":"Rutgeerts","year":"1990","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.dld.2007.01.012_bib26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0016-5085(98)70131-3","article-title":"Budesonide enema for the treatment of active distal Ulcerative Colitis and proctitis: a dose-ranging study","volume":"115","author":"Hanauer","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2007.01.012_bib27","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/gut.2004.060103","article-title":"Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild\/moderate active ulcerative colitis: a randomised, double-blind, placebo controlled study","volume":"54","author":"Marteau","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2007.01.012_bib28","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/BF01308084","article-title":"Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis","volume":"37","author":"Campieri","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2007.01.012_bib29","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/BF01296108","article-title":"Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema","volume":"38","author":"Campieri","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2007.01.012_bib30","first-page":"677","article-title":"Mesalazine for (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group","volume":"31","author":"Ardizzone","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2007.01.012_bib31","first-page":"1345","volume":"51","author":"Hammond","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.dld.2007.01.012_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2036.1994.tb00335.x","article-title":"Budesonide enema in active haemorragic proctitis\u2014a controlled trial against hydrocortisone foam enema","volume":"8","author":"Tarpila","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2007.01.012_bib33","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/gut.21.10.885","article-title":"Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam","volume":"21","author":"Ruddell","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.dld.2007.01.012_bib34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1590-8658(02)80072-X","article-title":"Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild\u2013moderate relapse of ulcerative colitis: one-year randomised multicentre trial","volume":"34","author":"Paoluzi","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2007.01.012_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.dld.2004.12.011","article-title":"Colonic targeting of aminosalicylates for the treatment of ulcerative colitis","volume":"37","author":"Klotz","year":"2005","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.dld.2007.01.012_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00054725-199509000-00007","article-title":"Medical therapy of ulcerative proctitis and proctosigmoiditis, including refractory disease","volume":"1","author":"Bitton","year":"1995","journal-title":"Inflamm Bowel Dis"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865807000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865807000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T06:54:41Z","timestamp":1556175281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865807000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1590865807000114"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2007.01.012","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}